Eli Lilly and Suven enter CNS research deal Eli Lilly and Suven enter CNS research deal 01-Sep-2006 By Wai Lang Chu Drug giant Eli Lilly has joined forces with Suven Life Sciences in a deal that will focus on pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders.